₹ 1,275.10
13.50 (1.07%)
E
Eris Lifesciences
₹ 1,275.10
Eris Lifesciences EPS Summary (consolidated)
The latest quarterly EPS of Eris Lifesciences as of Q2 Sep 2026 stands at ₹13.26. This is a 28.99% growth quarter on quarter and 50.34% growth same quarter last year. The forecasted EPS for Q2 Sep 2026 was ₹11.00. It beat the estimate by ₹2.26. For the FY2026 the EPS of Eris Lifesciences stands at ₹45.33. This is a 75.36% growth compared with FY2025.
Eris Lifesciences EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

